Grifols Timeline and History

Griffols is a global healthcare company with more than 13,000 people in 25 countries to improve people's health and well-being. We manufacture and sell plasma derived medicines, diagnostic systems, and hospital pharmacy products that save lives for the treatment of patients in more than 100 countries worldwide.

Grifols was founded in 1940 by Dr. José Antonio Milifols Lucas in Barcelona, ​​Spain. Since then, Griffols has been at the forefront of the plasma industry and a pioneer of complex technologies for chemical recovery, inspection and manufacture derived from plasma today. Over the years we have built a network of the world's largest plasma donor centers and have made Grifols the world leader in plasma collection and world leader in plasma derived drugs.

Our commitment to serve people is the center of everything we do. That is why we are trying hard to recruit talented people and create a vibrant and lively organization. As a company, we are proud to guarantee the quality, integrity and safety of everything we do - this is our center. After all, our products are crucial to the quality and health of the patients we serve.

Grifols has been involved in transfusion, blood banking, protein therapy, and laboratory analysis for more than 70 years. Dr. J.A. was founded in 1940. Since then, three generations of Grifols Roig of the Grifols family have lead the company. Today, Victor Grifols, our company's president of Grifols S.A., keeps the company constantly paying attention to the most important issues, people. We are focused on the world and we sell products in 90 countries.

Grifols was founded in 1940 by Dr. José Antonio Milifols Lucas in Barcelona, ​​Spain. Since then, Griffols has been at the forefront of the plasma industry and a pioneer of complex technologies for chemical recovery, inspection and manufacture derived from plasma today. Over the years we have built a network of the world's largest plasma donor centers and have made Grifols the world leader in plasma collection and world leader in plasma derived drugs. Our commitment to serve people is the center of everything we do. That is why we are trying hard to recruit talented people and create a vibrant and lively organization. As a company, we are proud to guarantee the quality, integrity and safety of everything we do - this is our center. After all, our products are crucial to the quality and health of the patients we serve.

Production is accelerating growth. For example, Gulfor is planning to expand to 225 donation centers from 171 in 2016 to 80 in 2010 in the coming years. The company 's revenue has increased six - fold between 2006 and 2016, during which time other companies have grown similarly, and in 2015 Grifolus gathered 26,000 donations a day worldwide Said. The company managed about one-fifth of the plasma treatment market in 2016. (Recent data has not been published since Grifols is not satisfied with the future annual report.)